Edwards Lifesciences (EW) Gross Margin (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Gross Margin of 78.01% for Q1 2026, down 65.0% year-over-year from 222.87% in Q1 2025, and little changed quarter-over-quarter from 78.15% in Q4 2025.
Edwards Lifesciences (EW) Gross Margin (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Gross Margin history runs 18 years deep, the most recent figure standing at 78.01% for Q1 2026.
- In Q1 2026, Gross Margin fell 65.0% year-over-year to 78.01%; the TTM figure through Mar 2026 stood at 77.87% (down 163.0% YoY), while the FY2025 annual figure was 78.01%, down 144.0% from the prior year.
- Gross Margin for Q1 2026 stood at 78.01%, roughly flat from 78.15% in the prior quarter.
- The five-year high for Gross Margin was 122.98% in Q4 2022, with the low at 77.52% in Q2 2025.
- The 5-year median for Gross Margin is 79.85% (2023), against an average of 81.86%.
- The sharpest annual moves came in 2022 and 2023: Gross Margin jumped 4626 bps in 2022, then slumped 4280 bps in 2023.
- Edwards Lifesciences' Gross Margin stood at 122.98% in 2022, then sank by 35 bps to 80.18% in 2023, then declined by 2 bps to 78.91% in 2024, then fell by 1 bps to 78.15% in 2025, then slipped by 0 bps to 78.01% in 2026.
- Business Quant data shows EW's Gross Margin at 78.01% in Q1 2026, 78.15% in Q4 2025, and 77.77% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.08 Bn | 194.48 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 129.71 Bn | 126.23 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 120.07 Bn | 110.85 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 74.08 Bn | 73.54 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.51 Bn | 32.56 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 34.03 Bn | 31.92 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.51 Bn | 23.19 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.20 Bn | 22.72 Bn | 684.20 Mn | 45.84% |
| 10 | Zimmer Biomet Holdings | 19.37 Bn | 18.96 Bn | 1.54 Bn | 70.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.46% |
| Mar 31, 2026 | 78.01% |
| Dec 31, 2025 | 78.15% |
| Sep 30, 2025 | 77.77% |
| Jun 30, 2025 | 77.52% |
| Mar 31, 2025 | 78.65% |
| Dec 31, 2024 | 78.91% |
| Sep 30, 2024 | 80.59% |
| Jun 30, 2024 | 79.88% |
| Mar 31, 2024 | 78.43% |
| Dec 31, 2023 | 80.18% |
| Sep 30, 2023 | 79.85% |
| Jun 30, 2023 | 80.62% |
| Mar 31, 2023 | 81.25% |
| Dec 31, 2022 | 122.98% |
| Sep 30, 2022 | 80.76% |
| Jun 30, 2022 | 80.39% |
| Mar 31, 2022 | 77.68% |
| Dec 31, 2021 | 76.72% |
| Sep 30, 2021 | 76.21% |